Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome [PDF]
Life, 2023 Most patients suffering from Lyme disease are effectively treated with antibiotics. In some patients, however, problems persist for a long time despite appropriate therapy.
Kristyna Sloupenska +10 more
doaj +2 more sources
Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome [PDF]
Microorganisms, 2021 The hypothesized importance of coinfections in the pathogenesis of post-treatment Lyme disease syndrome (PTLDS) leads to the use of combined, ongoing antimicrobial treatment in many cases despite the absence of symptoms typical of the presence of ...
Kristyna Sloupenska +9 more
doaj +2 more sources
Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease [PDF]
Frontiers in Medicine, 2020 It has long been observed in clinical practice that a subset of patients with Lyme disease report a constellation of symptoms such as fatigue, cognitive difficulties, and musculoskeletal pain, which may last for a significant period of time.
Alison W. Rebman, John N. Aucott
doaj +2 more sources
Neuroborreliosis and Post-Treatment Lyme Disease Syndrome: Focus on Children [PDF]
Life, 2023 Neuroborreliosis is a form of Lyme Borreliosis (LB) that affects various structures of the central and peripheral nervous system. Although most cases of LB can be cured with a course of antibiotics, some children can present prolonged symptoms, which may
Agnieszka Myszkowska-Torz +5 more
doaj +2 more sources
Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome? [PDF]
Frontiers in NeurologyDysautonomia, or dysfunction of the autonomic nervous system (ANS), may occur following an infectious insult and can result in a variety of debilitating, widespread, and often poorly recognized symptoms.
Brittany L. Adler +3 more
doaj +2 more sources
Annexin A2 antibodies in post-treatment Lyme disease [PDF]
Therapeutic Advances in Infectious DiseaseBackground: Anti-annexin A2 (AA2) antibodies have been described in Lyme arthritis and erythema migrans, although they have not been described in post-treatment Lyme disease (PTLD).
John B. Miller +5 more
doaj +2 more sources
Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review [PDF]
Antibiotics, 2022 Lyme disease and associated co-infections are increasing worldwide and approximately 20% of individuals develop chronic Lyme disease (CLD)/Post-Treatment Lyme Disease Syndrome (PTLDS) despite early antibiotics.
Richard I. Horowitz, Phyllis R. Freeman
doaj +2 more sources
Invalidation by medical professionals in post-treatment Lyme disease [PDF]
Scientific ReportsPatients with post-treatment Lyme disease (PTLD) report negative perceptions of care and significant invalidation from medical professionals. However, the relationship of invalidation to illness severity has not been examined, nor have risk factors for ...
Alison W. Rebman +2 more
doaj +2 more sources
Autoantibodies in post-treatment Lyme disease syndrome [PDF]
Frontiers in Neurology, 2022 Armin Alaedini +3 more
doaj +2 more sources
Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review [PDF]
Antibiotics, 2020 Three patients with multi-year histories of relapsing and remitting Lyme disease and associated co-infections despite extended antibiotic therapy were each given double-dose dapsone combination therapy (DDD CT) for a total of 7–8 weeks. At the completion
Richard I. Horowitz, Phyllis R. Freeman
doaj +2 more sources